{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:03:11Z","timestamp":1790020991201,"version":"4.0.1"},"reference-count":32,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Influenza Resp Viruses"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Seroprevalence studies have proven to be an important tool in tracking the progression of the coronavirus disease 2019 (COVID\u201019) pandemic. The aim of this study was to measure the seroprevalence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102) in the general population of Kosovo by gender, age group and region and among asymptomatic people.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>The Institute of Public Health of Kosovo conducted a cross\u2010sectional population\u2010based survey, aligned with the protocols of the WHO Unity Studies, from the beginning of May to the end of June 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The survey covered a total of 2204 people with a response rate of 91.8% (41.9% [923] males and 51.2% [1281] females). In May to June 2021, the prevalence of antibodies in the overall population (IgG antibodies\u2009\u2265\u20091.1) was 37.0%. Seroprevalence was 34.4% in men and 38.9% in women (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), with the highest percentage (48.7%) found in the 60\u201369\u2009years' age group. The overall prevalence of acute IgM antibodies (IgM\u2009\u2265\u20091.1) was 1% (95% CI: 0.7%\u20131.5%), with no significant difference between genders and the highest prevalence among participants of 60\u201369\u2009years of age (1.6%; 95% CI: 0.7%\u20133.6%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A high prevalence of antibodies against SARS\u2010CoV\u20102 was found in Kosovo before the start of the vaccination campaign. However, the results of the survey suggested that, by the end of June 2021, a desirable level of protection from the SARS\u2010CoV\u20102 virus had not been reached.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/irv.70004","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T05:14:21Z","timestamp":1725340461000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prevalence of SARS\u2010CoV\u20102 Antibodies in Kosovo\u2010Wide Population\u2010Based Seroepidemiological Study"],"prefix":"10.1111","volume":"18","author":[{"given":"Naser","family":"Ramadani","sequence":"first","affiliation":[{"name":"Faculty of Medicine University of Pristina \u201cHasan Pristina\u201d  Pristina Kosovo"},{"name":"National Institute of Public Health  Pristina Kosovo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4810-0401","authenticated-orcid":false,"given":"Sanije","family":"Hoxha\u2010Gashi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine University of Pristina \u201cHasan Pristina\u201d  Pristina Kosovo"},{"name":"National Institute of Public Health  Pristina Kosovo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafina","family":"Gexha\u2010Bunjaku","sequence":"additional","affiliation":[{"name":"National Institute of Public Health  Pristina Kosovo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arijana","family":"Kalaveshi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine University of Pristina \u201cHasan Pristina\u201d  Pristina Kosovo"},{"name":"National Institute of Public Health  Pristina Kosovo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xhevat","family":"Jakupi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine University of Pristina \u201cHasan Pristina\u201d  Pristina Kosovo"},{"name":"National Institute of Public Health  Pristina Kosovo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isme","family":"Humolli","sequence":"additional","affiliation":[{"name":"WHO Office in Pristina  Pristina Kosovo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling","family":"Vaughan","sequence":"additional","affiliation":[{"name":"WHO Regional Office for Europe  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Pebody","sequence":"additional","affiliation":[{"name":"WHO Regional Office for Europe  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranvera","family":"Kacaniku\u2010Gunga","sequence":"additional","affiliation":[{"name":"National Institute of Public Health  Pristina Kosovo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Jashari","sequence":"additional","affiliation":[{"name":"National Institute of Public Health  Pristina Kosovo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,9,3]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(20)30183\u20105"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017"},{"key":"e_1_2_10_4_1","unstructured":"\u201cWHO Statement on Novel Coronavirus in Thailand \u201d in News release World Health Organization [Website] January 13 2020 (Geneva: World Health Organization 2023) accessed October 18 2023 https:\/\/www.who.int\/news\/item\/13\u201001\u20102020\u2010who\u2010statement\u2010on\u2010novel\u2010coronavirus\u2010in\u2010thailand."},{"key":"e_1_2_10_5_1","unstructured":"\u201cWHO Director\u2010General's Opening Remarks at the Media Briefing on COVID\u201019 \u201d World Health Organization [Website] March 11 2020 (Geneva: World Health Organization 2023) accessed October 18 2023 https:\/\/www.who.int\/director\u2010general\/speeches\/detail\/who\u2010director\u2010general\u2010s\u2010opening\u2010remarks\u2010at\u2010the\u2010media\u2010briefing\u2010on\u2010covid\u201019\u2010\u2010\u201011\u2010march\u20102020."},{"key":"e_1_2_10_6_1","unstructured":"\u201cWHO Coronavirus Disease (COVID\u201019) Dashboard [Database]\u201d (Geneva: World Health Organization 2023) accessed October 18 2023 https:\/\/covid19.who.int\/."},{"key":"e_1_2_10_7_1","unstructured":"\u201cKosova n\u00ebshifra 2021 Kosovo in Code 2021\u201d (Prishtina: Kosovo Agency of Statistics 2022)."},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.52152\/spr\/2021.118"},{"key":"e_1_2_10_9_1","unstructured":"\u201cCOVID\u201019 Data From the Institute of Public Health as of 8th May 2022 \u201d Institute of Public Health of Kosovo."},{"key":"e_1_2_10_10_1","unstructured":"\u201cNis vaksinimi masiv MSH\u2010ja thot\u00eb se ka doza t\u00eb mjaftueshme. 15 Gershor 2021 [Mass Vaccination Starting the Ministry of Health Says There Are Enough Doses 15 January 2021] \u201d in Radio Evropa e Lir\u00eb \u2013 Lajmet [Radio Free Europe \u2013 News] [Website] (Prague: Radio Free Europe 2023) accessed October 18 2023 https:\/\/www.evropaelire.org\/a\/vaksinimi\u2010masiv\u2010ne\u2010kosove\u2010\/31308445.html."},{"key":"e_1_2_10_11_1","unstructured":"\u201cT\u00eb mart\u00ebn pritet t\u00eb nis vaksinimi masiv n\u00eb Kosov\u00eb nd\u00ebrkoh\u00eb n\u00eb dispozicion jan\u00eb vet\u00ebm 97 mij\u00eb vaksina [Mass vaccination is Expected to Start in Kosovo on Tuesday While Only 97 000 Vaccines Are Available]\u201d in telegrafi [website] (Pristina: Telegrafi sh.p.k. 2022) accessed October 18 2023 https:\/\/telegrafi.com\/te\u2010marten\u2010pritet\u2010te\u2010nis\u2010vaksinimi\u2010masiv\u2010ne\u2010kosove\u2010nderkohe\u2010ne\u2010dispozicion\u2010jane\u2010vetem\u201097\u2010mije\u2010vaksina\/."},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252617"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19547"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10060774"},{"key":"e_1_2_10_15_1","unstructured":"\u201cPopulation\u2010Based Age\u2010Stratified Seroepidemiological Investigation Protocol for COVID\u201019 Virus Infection\u201d (Geneva: World Health Organization 2020) accessed October 18 2023 https:\/\/www.who.int\/publications\/i\/item\/WHO\u20102019\u2010nCoV\u2010Seroepidemiology\u20102020.2."},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2021.105064"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2023.101208"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahjo.2021.100011"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004107"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0266945"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.onehlt.2021.100292"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473\u20103099(20)30631\u20109"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.658544"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10654\u2010021\u201000796\u20108"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyab010"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100801"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.2144\/fsoa\u20102020\u20100203"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560\u20107917.ES.2020.25.31.2001369"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2021.01.029"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(20)31304\u20100"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467\u2010021\u201022"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560\u20107917.ES.2022.27.9.2100419"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.12932\/AP\u2010040721\u20101177"}],"container-title":["Influenza and Other Respiratory Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/irv.70004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T22:45:12Z","timestamp":1728600312000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/irv.70004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1111\/irv.70004"],"URL":"https:\/\/doi.org\/10.1111\/irv.70004","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1111\/IRV.70004\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/IRV.70004\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/IRV.70004\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/IRV.70004\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/IRV.70004\/v3\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/IRV.70004\/v3\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/IRV.70004\/v2\/decision1","asserted-by":"object"}]},"ISSN":["1750-2640","1750-2659"],"issn-type":[{"value":"1750-2640","type":"print"},{"value":"1750-2659","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"2024-02-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70004"}}